Ligand Pharmaceuticals (LGND)
(Delayed Data from NSDQ)
$73.90 USD
+1.58 (2.18%)
Updated May 3, 2024 04:00 PM ET
After-Market: $73.99 +0.09 (0.12%) 7:58 PM ET
1-Strong Buy of 5 1
D Value D Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC5/7/24 |
---|---|
Current Quarter | 1.13 |
EPS Last Quarter | 1.05 |
Last EPS Surprise | 81.03% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 4.56 |
Next Year | 5.27 |
EPS (TTM) | 5.77 |
P/E (F1) | 16.21 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 32.50M | 34.33M | 139.25M | 156.75M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 33.39M | 35.05M | 141.30M | 159.69M |
Low Estimate | 31.61M | 33.61M | 137.20M | 153.80M |
Year ago Sales | 43.98M | 26.37M | 131.31M | 139.25M |
Year over Year Growth Est. | -26.10% | 30.19% | 6.04% | 12.56% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.13 | 1.11 | 4.56 | 5.27 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | 1.13 | 1.11 | 4.56 | 5.27 |
High Estimate | 1.13 | 1.11 | 4.56 | 5.27 |
Low Estimate | 1.13 | 1.11 | 4.56 | 5.27 |
Year ago EPS | 2.28 | 1.42 | 4.06 | 4.56 |
Year over Year Growth Est. | -50.44% | -21.83% | 12.32% | 15.57% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 1.13 | 1.11 | 4.56 | 5.27 |
7 Days Ago | 1.13 | 1.11 | 4.56 | 5.27 |
30 Days Ago | 1.13 | 1.11 | 4.56 | 5.27 |
60 Days Ago | 1.07 | 1.04 | 4.42 | 5.11 |
90 Days Ago | 1.07 | 1.04 | 4.42 | 5.11 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 1.13 | 1.11 | 4.56 | 5.27 |
Zacks Consensus Estimate | 1.13 | 1.11 | 4.56 | 5.27 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.05 | 1.02 | 1.42 | 2.28 | NA |
Estimate | 0.58 | 0.68 | 0.76 | 1.03 | NA |
Difference | 0.47 | 0.34 | 0.66 | 1.25 | 0.68 |
Surprise | 81.03% | 50.00% | 86.84% | 121.36% | 84.81% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more